Columbia, MO, United States
Columbia, MO, United States

Time filter

Source Type

Global Medical Aesthetics Market Forecast to 2024 – New Report by Data Bridge Market Research Global Medical Aesthetic Market, By Product Type (Aesthetic Laser Devices, Energy Devices, Skin Tightening and Body Contouring Devices, Aesthetic Implants, Facial Aesthetic Devices), By Applications (Anti Aging and Wrinkles, Facial & Skin Rejuvenation, Vascular Lesions, Body shaping & cellulite, Breast Enhancement, Scars, Pigment Lesions, Reconstructive Surgery, Tattoo Removal, Psoriasis & Vitilgo, Skin Surgery), End-User, Distribution Channel, Geography – Industry Trends and Forecast to 2024 Dallas, TX, February 18, 2017 --( The global medical aesthetic devices market is segmented on the basis of product type, application, end-user, distribution channel and geography. On the basis of product type the market is segmented into Aesthetic Laser devices which is further sub divided into Fractional Carbon Dioxide Laser Resurfacing, Ablative Skin Resurfacing Devices, Non-Ablative Fractional Laser Skin Resurfacing; Energy Devices which is further segmented into Electrocautery, Electrosurgery, Cryosurgery, Laser surgery, Microwave, Harmonic scalpel. Based on application the market is segmented into food and beverage testing, pharmaceutical, industrial, environmental testing, geological sciences, petrochemical, academics and, others. On the basis of application the market is segmented into anti aging and wrinkles, facial & skin rejuvenation, vascular lesions, body shaping & cellulite, breast enhancement, scars, pigment lesions, reconstructive surgery, tattoo removal, hair removal, psoriasis & vitilgo, skin tightening and others. Based on end user the market is segmented into hospitals, dermatology clinics, cosmetic centers, medical spas & beauty center. Request for sample pages: https://databridgemarketresearch.com/reports/global-medical-aesthetics-market/ Based on geography the market is segmented into 5 geographical regions, North America, Europe, Asia-Pacific, South America and Middle East and Africa. The report of this market covers data for countries such as U.S. Canada, Mexico, Germany, France, U.K., Belgium, Switzerland, Belgium, Turkey, Japan, China, Singapore, Brazil, India, Russia, and South Africa. Read more: https://databridgemarketresearch.com/medical-aesthetics-market-poised-grow-8-6/ The key players operating in this market are Allergan plc, Neograft Technologies Inc, BTL Aesthetics, Galderma S.A., Thermi, Merz Pharma Gmbh & Co, Surgical Specialties Corporation, Suneva Medical, Venus concept, Valeant Pharmaceuticals International, Sientra Inc, Cynosure Inc, Revance Therapeutics Inc, Zeltiq Aesthetics Inc, Dynatronics Corporation, EternoGen Aesthetics, GC Aesthetics, Obagi Skin Health Institute, Dermatology Associates, Alma Lasers GmbH, Cutera Inc, Cynosure Inc, Ellman International Inc, Genesis Biosystems Inc, Iridex Corporation, PhotoMedex Inc, Sciton Inc, Smith & Nephew Healthcare Pvt. Ltd., Solta Medical Corporate, Syneron Medical Ltd, Laboratories Vivacy, Prollenium Medical Technologies among others. About Data Bridge Market Research: Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Dallas, TX, February 18, 2017 --( PR.com )-- The Global medical aesthetics market is expected to reach USD 16.1 billion by 2024 from USD 8.33 billion in 2016, at a CAGR of 8.6% in the forecast period 2017 to 2024. The new market report contains data for historic years 2014 & 2015, the base year of calculation is 2016 and the forecast period is 2017 to 2024.The global medical aesthetic devices market is segmented on the basis of product type, application, end-user, distribution channel and geography.On the basis of product type the market is segmented into Aesthetic Laser devices which is further sub divided into Fractional Carbon Dioxide Laser Resurfacing, Ablative Skin Resurfacing Devices, Non-Ablative Fractional Laser Skin Resurfacing; Energy Devices which is further segmented into Electrocautery, Electrosurgery, Cryosurgery, Laser surgery, Microwave, Harmonic scalpel. Based on application the market is segmented into food and beverage testing, pharmaceutical, industrial, environmental testing, geological sciences, petrochemical, academics and, others.On the basis of application the market is segmented into anti aging and wrinkles, facial & skin rejuvenation, vascular lesions, body shaping & cellulite, breast enhancement, scars, pigment lesions, reconstructive surgery, tattoo removal, hair removal, psoriasis & vitilgo, skin tightening and others.Based on end user the market is segmented into hospitals, dermatology clinics, cosmetic centers, medical spas & beauty center.Request for sample pages: https://databridgemarketresearch.com/reports/global-medical-aesthetics-market/Based on geography the market is segmented into 5 geographical regions, North America, Europe, Asia-Pacific, South America and Middle East and Africa. The report of this market covers data for countries such as U.S. Canada, Mexico, Germany, France, U.K., Belgium, Switzerland, Belgium, Turkey, Japan, China, Singapore, Brazil, India, Russia, and South Africa.Read more: https://databridgemarketresearch.com/medical-aesthetics-market-poised-grow-8-6/The key players operating in this market are Allergan plc, Neograft Technologies Inc, BTL Aesthetics, Galderma S.A., Thermi, Merz Pharma Gmbh & Co, Surgical Specialties Corporation, Suneva Medical, Venus concept, Valeant Pharmaceuticals International, Sientra Inc, Cynosure Inc, Revance Therapeutics Inc, Zeltiq Aesthetics Inc, Dynatronics Corporation, EternoGen Aesthetics, GC Aesthetics, Obagi Skin Health Institute, Dermatology Associates, Alma Lasers GmbH, Cutera Inc, Cynosure Inc, Ellman International Inc, Genesis Biosystems Inc, Iridex Corporation, PhotoMedex Inc, Sciton Inc, Smith & Nephew Healthcare Pvt. Ltd., Solta Medical Corporate, Syneron Medical Ltd, Laboratories Vivacy, Prollenium Medical Technologies among others.About Data Bridge Market Research:Data Bridge set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process. Click here to view the list of recent Press Releases from Data Bridge Market Research


Devore D.,EternoGen | Zhu J.,EternoGen | Brooks R.,EternoGen | McCrate R.R.,EternoGen | And 2 more authors.
Journal of Biomedical Materials Research - Part A | Year: 2016

A liquid collagen has been developed that fibrilizes upon injection. Rapid polymerizing collagen (RPC) is a type I porcine collagen that undergoes fibrillization upon interaction with ionic solutions, such as physiological solutions. The ability to inject liquid collagen would be beneficial for many soft tissue augmentation applications. In this study, RPC was synthesized and characterized as a possible dermal filler. Transmission electron microscopy, ion induced RPC fibrillogenesis tests, collagenase resistance assay, and injection force studies were performed to assess RPC's physicochemical properties. An in vivo study was performed which consisted of a 1-, 3-, and 6-month study where RPC was injected into the ears of miniature swine. The results demonstrated that the liquid RPC requires low injection force (<7 N); fibrillogenesis and banding of collagen occurs when RPC is injected into ionic solutions, and RPC has enhanced resistance to collagenase breakdown. The in vivo study demonstrated long-term biocompatibility with low irritation scores. In conclusion RPC possesses many of the desirable properties of a soft tissue augmentation material. © 2015 Wiley Periodicals, Inc.


PubMed | University of Missouri and EternoGen
Type: | Journal: Journal of biomedical materials research. Part A | Year: 2015

A liquid collagen has been developed that fibrilizes upon injection. Rapid polymerizing collagen (RPC) is a type I porcine collagen that undergoes fibrillization upon interaction with ionic solutions, such as physiological solutions. The ability to inject liquid collagen would be beneficial for many soft tissue augmentation applications. In this study, RPC was synthesized and characterized as a possible dermal filler. Transmission electron microscopy, ion induced RPC fibrillogenesis tests, collagenase resistance assay, and injection force studies were performed to assess RPCs physicochemical properties. An in vivo study was performed which consisted of a 1, 3, and 6 month study where RPC was injected into the ears of miniature swine. The results demonstrated that the liquid RPC requires low injection force (<7N); fibrillogenesis and banding of collagen occurs when RPC is injected into ionic solutions, and RPC has enhanced resistance to collagenase breakdown. The in vivo study demonstrated long-term biocompatibility with low irritation scores. In conclusion RPC possesses many of the desirable properties of a soft tissue augmentation material. This article is protected by copyright. All rights reserved.


Patent
EternoGen | Date: 2014-03-04

The present invention is directed to injectable acid soluble collagen compositions comprising a neutralized solution of an acid soluble collagen, EDTA and preferably a polyol, wherein the composition is injectable at physiological pH and the acid soluble collagen polymerizes upon exposure to tissue. The invention is suitable for use in soft tissue augmentation, promoting soft tissue regeneration and coating medical implants and devices.


Trademark
EternoGen | Date: 2014-09-10

Injectable dermal filler. Skin treatment, namely, the injection of dermal fillers to reduce the appearance of facial fine lines.


Trademark
EternoGen | Date: 2015-04-22

Injectable dermal filler. Skin treatment, namely, the injection of dermal fillers to reduce the appearance of facial fine lines.


EternoGen | Entity website

Management Team EternoGen Aesthetics is led by a group of proven industry veterans with decades of collective leadership experience in medical aesthetics. They have been responsible for the development, launch and exits of a number of the industry leading brands including RESTYLANE ...


Investor Relations EternoGen has secured $1.8 million, which has driven product development and optimization ...


Bio-Dermal RestorationNaturally Reinforce Skin


Loading EternoGen collaborators
Loading EternoGen collaborators